Kyprolis FDA Approval Expanded for Relapsed or Refractory Multiple Myeloma
New Multiple Myeloma Drug JS-K Making its Way Through the Drug Development Process
Dr. Paul Shami, MD of the Huntsman Cancer Institute shares his work on a new drug called JS-K, now in development for multiple myeloma and other cancers...
The Hopeful Future of Multiple Myeloma in 2016 with Dr. Kenneth Anderson, MD, PhD, Dana Farber Cancer Institute
Dr. Kenneth Anderson, MD, PhD of the Dana Farber Cancer Institute joins Myeloma Crowd Radio to outline the most important work being done in multiple myeloma...
Multiple Myeloma WT1 Vaccine from Memorial Sloan Kettering Showing Progress
Is The CANCER MOONSHOT The Only Solution To An Inadequate And Outdated System?
Magic Bullets to Moon Shots
Oncolytics Biotech Inc Announces Start of Enrollment in Phase 1b Study of Multiple Myeloma Looking at REOLYSIN® in Combination with Bortezomib
Celgene's Revlimid now approved for Multiple Myeloma in Japan
An Incredible Year for Multiple Myeloma. Highlights with Dr. Robert Orlowski, MD, PhD, MD Anderson
This will be remembered as a banner year for multiple myeloma with the introduction of 5 new FDA-approved drugs. Dr. Orlowski gives us his take on the year...
A New Treatment Option? Merck Immunotherapy Keytruda Shows Promise in Multiple Myeloma Trial
Washington Post: For Multiple Myeloma Community, a November to Remember
Does Sugar Feed Cancer? - Part 2: Cancer & Nutrition
The Future of Treating Myeloma? Anti–B-Cell Maturation Antigen CAR T Cells Show Promise for Advanced Disease
CAR T Cell Breakthrough Announced at ASH 2015
Cancer & Nutrition: Does Sugar Feed Cancer?
From LLS: Making Sense of the Two New Drugs Approved for Treating Myeloma & What's Ahead
BREAKING NEWS: FDA Approves Darzalex (daratumumab) for Patients with Previously Treated Myeloma
SCT Postcard From the Edge: Surviving My 5-Day Hospital Stay For Myeloma
Patient Power: How To Handle The Emotional Aspects of a Cancer Diagnosis
Why an Early Myeloma Diagnosis Matters and Why I Support the MCRI by Linda Lloyd
MCRI Day 12 Challenge: Devon Harris and The Jamaican Bobsled Team Push for Better Outcomes for Multiple Myeloma
MedPage Today: Searching For High Risk Precursors In Multiple Myeloma
MCRI Day 9 Challenge: Teach Your Primary Care Doctor How to Diagnose Myeloma and Save Lives
Some Myeloma Patients With del(17p) or t(4:14) Fare Better Than Others
